OptimizeRx has released its second Environment, Social and Governance (ESG) report. The report details the Company’s efforts to align with, and show progress against, the 21 core Stakeholder Capitalism metrics as outlined by the World Economic Forum.
The key metrics are used to provide a benchmark to measure initiatives, performance, and strategies that provide both transparency and accountability to the most significant economic, social, and environmental impacts that result from the Company’s activities. The metrics remain distributed across the four categories of Governance, Planet, People, and Prosperity.
“This ESG report demonstrates the efforts we make to serve a bigger purpose than ourselves,” commented Will Febbo, OptimizeRx Chief Executive Officer.
The Report Highlights Include:
We stand by strong ESG principles of governance - by aligning financial and societal performance and ensuring accountability with stakeholders - that is foundational to achieving long-term value. Integrating ESG values into all aspects of our business is a journey. The pursuit of ESG Principles of Governance is a top-down endeavor, and the Company’s Board of Directors and the Nominating & Governance Committee are working closely with the Executive Team to ensure our business strategies and practices align with our corporate governance policies. In addition, in 2023, we updated our inaugural materiality matrix to identify the critical issues affecting our business and stakeholders. We continue to evolve while fostering an inclusive organization with a strong governing structure that supports long-term sustainability and social responsibility. We will continue to build on our ESG momentum as we refine and measure impact.
In 2023, we achieved a significant milestone in our ESG journey by conducting a preliminary review of the Scope 1 and 2 emissions resulting from our US operations that aligns with the requirements for reporting Scope 1 and 2 emissions as outlined in the Greenhouse Gas Protocol – standards set by the World Business Council for Sustainable Development and World Resources Institute.
OptimizeRx continues to provide a supportive and respectful environment for its employees. Understanding that diversity in all areas is essential to bettering a professional environment, OptimizeRx celebrates differences in cultural background, experience, and thought by fostering an inclusive and collaborative atmosphere. We prioritize recruiting, retaining, and incentivizing a highly qualified workforce as the success of OptimizeRx is dependent on the skills, experience, and efforts of our employees. A skilled workforce not only improves a company’s performance but also contributes to overall employee satisfaction and enhances human capital.
Innovation remains key to our success as a health technology company. Through technology innovation, OptimizeRx aims to create more, and better, digital solutions that respond to the current unmet needs of the US health system and anticipate future needs related to patient care journeys. We will continue to invest in research and development efforts that have direct impact on population health challenges, including health communications, patient affordability, cost of care delivery, equitable access to therapy, and medication non-adherence.
“We continue to stay true to our mission and purpose ― to create a more informed and empowered healthcare community by developing new technology solutions that help people start and stay on life-impacting therapies. This ESG report demonstrates the efforts we make to serve a bigger purpose than ourselves,” commented Will Febbo, OptimizeRx Chief Executive Officer. “OptimizeRx continues to support its community through philanthropic efforts, including individual contributions from our employees and board members. We are proud of the positive impact we have on our communities, our employees, and the greater good.”
To read the report, visit this link.